U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076355) titled 'Ultrasound-Guided Botulinum Toxin A Injection for TMJ Disc Displacement With Reduction' on July 14.
Brief Summary: This clinical trial was designed to evaluate the effectiveness of ultrasonography-guided botulinum toxin type A (BTX-A) injection into the lateral pterygoid muscle for the management of temporomandibular joint (TMJ) anterior disc displacement with reduction (ADDwR). Ten patients diagnosed with ADDwR participated in the study. Each patient received an ultrasound-guided injection of 25 units of BTX-A into the lateral pterygoid muscle under local anesthesia. Clinical evaluations were performed preoperatively and at 2, 6, 1...